LOW-VOLUME · SEX-THIN
plazomicin Side Effects
plazomicin (also sold as Zemdri) is a LOW-VOLUME FAERS extract #524 of 524 by FAERS report count. Still opens on SEX-THIN: sex coding is thin (2 known).
Data updated 2026-05-15
- 3
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
plazomicin reporting skew - sex coding is thin (2 known). Volume band LOW-VOLUME #524 of 524 by FAERS report count; caseload TRACE-CASE.
Thinner FAERS extract for plazomicin (Zemdri) (3 reports #524 of 524 by FAERS report count). sex coding is thin (2 known). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2021–2022). Stamps TRACE-CASE · DEATH-RARE · HOSP-HEAVY · SEX-THIN.
ACUTE KIDNEY INJURY leads 1 of 3 reports
Who reports · age peak 18-44 (SEX-THIN)
Sex coding · SEX-THIN
Age peak 18-44 (1 reports)
FAERS filings rising toward 2022
Reactions in Hospitalization Reports
Hospitalization is HEAVY (1, 33.3% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| CREATININE RENAL CLEARANCE DECREASED | 1 |
| RENAL FAILURE | 1 |
How to read plazomicin FAERS figures (TRACE-CASE · DEATH-RARE · HOSP-HEAVY)
FAERS holds 3 voluntary reports linked to plazomicin (Zemdri), 2021-2022. No death outcome in this extract. Hospitalization appears on 1 (33.3%). Top co-reported indication: Infusion.
Sparse extract - named reactions and SEX-THIN skew still differ by drug; not a complete safety profile.
Read with plazomicin
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-RARE · HOSP-HEAVY stamps.
ABS(total_reports) peer at 51 FAERS cases (Δ 48 heavier vs plazomicin); DEATH-HEAVY · HOSP-HEAVY · SEX-THIN vs this page's TRACE-CASE · DEATH-RARE · HOSP-HEAVY · SEX-THIN.
ABS(total_reports) peer at 67 FAERS cases (Δ 64 heavier vs plazomicin); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's TRACE-CASE · DEATH-RARE · HOSP-HEAVY · SEX-THIN.
ABS(total_reports) peer at 73 FAERS cases (Δ 70 heavier vs plazomicin); DEATH-HEAVY · HOSP-MID · FEMALE-LED vs this page's TRACE-CASE · DEATH-RARE · HOSP-HEAVY · SEX-THIN.
ABS(total_reports) peer at 81 FAERS cases (Δ 78 heavier vs plazomicin); DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED vs this page's TRACE-CASE · DEATH-RARE · HOSP-HEAVY · SEX-THIN.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 62.1 pp vs plazomicin's DEATH-RARE): CASELOAD · HOSP-MID.
plazomicin stamps DEATH-RARE · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload TRACE-CASE and the label guide.